{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:02:21Z","timestamp":1780995741717,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to evaluate the effectiveness of combining a nitric oxide microparticle delivery system (NO-MP) with various FDA-approved PDE5 inhibitors (PDE5i) for improving erectile responses in a rat model of erectile dysfunction (ED) following cavernous nerve injury, similar to the effects of radical prostatectomy. Male Sprague-Dawley rats, 4\u20135 months old (weighing ~275\u2009g) underwent bilateral cavernous nerve transection. One week post-surgery animals were administered PDE5i via oral gavage (sildenafil 0.05\u2009mg\/kg (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20099), tadalafil 0.005\u2009mg\/kg (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20098), vardenafil 0.01\u2009mg\/kg (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20097), avanafil 0.1\u2009mg\/kg (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20098) or untreated (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20095) followed by topical application of 250\u2009mg NO-MP to the penile dermis. Erectile responses were assessed by measuring intracorporeal pressure (ICP) and systemic blood pressure (BP) after the application of NO-MP. Compared to NO-MP alone, combination therapy with a PDE5i significantly (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05) reduced the time to initial erectile response from 63\u2009\u00b1\u200921.6\u2009min to 8\u201323\u2009min (vardenafil: 23\u2009\u00b1\u20092.3, avanafil: 11\u2009\u00b1\u20098.1, sildenafil: 19.9\u2009\u00b1\u20099.8, tadalafil: 18\u2009\u00b1\u200912.8), and increased the frequency of spontaneous erections from 1\u2009\u00b1\u20090.71 to 1.7\u20132.7 per hour (vardenafil: 2.1\u2009\u00b1\u20090.9, avanafil: 2.7\u2009\u00b1\u20091.1, sildenafil: 1.7\u2009\u00b1\u20090.6, tadalafil: 2.5\u2009\u00b1\u20090.8). No significant changes in maximal ICP\/BP, duration of erectile response or baseline ICP\/BP were observed. These results suggest that combining NO-MP with PDE5i may provide a promising approach for treating ED after radical prostatectomy.\n                  <\/jats:p>","DOI":"10.1038\/s41443-025-01147-x","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:40:22Z","timestamp":1754563222000},"page":"486-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergy between oral PDE5 inhibitors and topically applied nitric oxide microparticles on the erectile response in a rat model of cavernous nerve injury"],"prefix":"10.1038","volume":"38","author":[{"given":"Moses T.","family":"Tar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Draganski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-9210","authenticated-orcid":false,"given":"Kelvin P.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","volume":"368","author":"MJ Resnick","year":"2013","unstructured":"Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436\u201345.","journal-title":"N Engl J Med"},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrurol.2009.126","volume":"6","author":"A Magheli","year":"2009","unstructured":"Magheli A, Burnett AL. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol. 2009;6:415\u201327.","journal-title":"Nat Rev Urol"},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1743-6109.2008.01105.x","volume":"6","author":"MG Ferrini","year":"2009","unstructured":"Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med. 2009;6:415\u201328.","journal-title":"J Sex Med"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S1470-2045(18)30357-7","volume":"19","author":"GD Coughlin","year":"2018","unstructured":"Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19:1051\u201360.","journal-title":"Lancet Oncol"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1743-6109.2006.00270.x","volume":"3","author":"AL Burnett","year":"2006","unstructured":"Burnett AL. Nitric oxide in the penis\u2014science and therapeutic implications from erectile dysfunction to priapism. J Sex Med. 2006;3:578\u201382.","journal-title":"J Sex Med"},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.2174\/138161205774913381","volume":"11","author":"AL Burnett","year":"2005","unstructured":"Burnett AL, Musicki B. The nitric oxide signaling pathway in the penis. Curr Pharm Des. 2005;11:3987\u201394.","journal-title":"Curr Pharm Des"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/PPA.S56002","volume":"9","author":"JD Evans","year":"2015","unstructured":"Evans JD, Hill SR. A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil. Patient Prefer Adherence. 2015;9:1159\u201364.","journal-title":"Patient Prefer Adherence"},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.sxmr.2017.08.001","volume":"6","author":"FA Yafi","year":"2018","unstructured":"Yafi FA, Sharlip ID, Becher EF. Update on the safety of phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. Sex Med Rev. 2018;6:242\u201352.","journal-title":"Sex Med Rev"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0090-4295(99)00371-4","volume":"55","author":"CG Stief","year":"2000","unstructured":"Stief CG, Uckert S, Becker AJ, Harringer W, Truss MC, Forssmann WG, et al. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology. 2000;55:146\u201350.","journal-title":"Urology"},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/jsm.12705","volume":"11","author":"M Tar","year":"2014","unstructured":"Tar M, Cabrales P, Navati M, Adler B, Nacharaju P, Friedman AJ, et al. Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med. 2014;11:2903\u201314.","journal-title":"J Sex Med"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1743-6109.2009.01507.x","volume":"7","author":"G Han","year":"2010","unstructured":"Han G, Tar M, Kuppam DS, Friedman A, Melman A, Friedman J, et al. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med. 2010;7:224\u201333.","journal-title":"J Sex Med"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41443-021-00451-6","volume":"34","author":"MT Tar","year":"2022","unstructured":"Tar MT, Friedman JM, Draganski A, Davies KP. Topically delivered nitric oxide acts synergistically with an orally administered PDE5 inhibitor in eliciting an erectile response in a rat model of radical prostatectomy. Int J Impot Res. 2022;34:573\u201380.","journal-title":"Int J Impot Res"},{"key":"1147_CR13","first-page":"1197","volume":"167","author":"I Goldstein","year":"2002","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, et al. Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol. 2002;167:1197\u2013203.","journal-title":"1998. J Urol"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1743-6109.2011.02629.x","volume":"9","author":"I Goldstein","year":"2012","unstructured":"Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9:1122\u201333.","journal-title":"J Sex Med"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2164\/jandrol.05026","volume":"26","author":"WJ Hellstrom","year":"2005","unstructured":"Hellstrom WJ, Elhilali M, Homering M, Taylor T, Gittleman M. Vardenafil in patients with erectile dysfunction: achieving treatment optimization. J Androl. 2005;26:604\u20139.","journal-title":"J Androl"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","volume":"62","author":"H Porst","year":"2003","unstructured":"Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36h after dosing: a randomized controlled trial. Urology. 2003;62:121\u20135.","journal-title":"Urology"},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0022-5347(17)38348-9","volume":"145","author":"DM Quinlan","year":"1991","unstructured":"Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol. 1991;145:380\u20133.","journal-title":"J Urol"},{"key":"1147_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jsxm.2018.03.009","volume":"15","author":"A Draganski","year":"2018","unstructured":"Draganski A, Tar MT, Villegas G, Friedman JM, Davies KP. Topically applied curcumin-loaded nanoparticles treat erectile dysfunction in a rat model of type 2 diabetes. J Sex Med. 2018;15:645\u201353.","journal-title":"J Sex Med"},{"key":"1147_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0090-4295(97)00693-6","volume":"51","author":"J Rehman","year":"1998","unstructured":"Rehman J, Christ G, Melman A, Fleischmann J. Intracavernous pressure responses to physical and electrical stimulation of the cavernous nerve in rats. Urology. 1998;51:640\u20134.","journal-title":"Urology"},{"key":"1147_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/alr.22185","volume":"8","author":"WM Abuzeid","year":"2018","unstructured":"Abuzeid WM, Girish VM, Fastenberg JH, Draganski AR, Lee AY, Nosanchuk JD, et al. Nitric oxide-releasing microparticles as a potent antimicrobial therapeutic against chronic rhinosinusitis bacterial isolates. Int Forum Allergy Rhinol. 2018;8:1190\u20138.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/aja.2009.70","volume":"12","author":"S Gur","year":"2010","unstructured":"Gur S, Sikka SC, Knight GE, Burnstock G, Hellstrom WJ. Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil. Asian J Androl. 2010;12:415\u201321.","journal-title":"Asian J Androl"},{"key":"1147_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138484","volume":"6","author":"L Baker","year":"2021","unstructured":"Baker L, Tar M, Kramer AH, Villegas GA, Charafeddine RA, Vafaeva O, et al. Fidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration. JCI Insight. 2021;6:e141800.","journal-title":"JCI Insight"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00345-008-0283-y","volume":"26","author":"SS Connolly","year":"2008","unstructured":"Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J Urol. 2008;26:333\u20139.","journal-title":"World J Urol"},{"key":"1147_CR24","first-page":"R441","volume":"276","author":"J Bernabe","year":"1999","unstructured":"Bernabe J, Rampin O, Sachs BD, Giuliano F. Intracavernous pressure during erection in rats: an integrative approach based on telemetric recording. Am J Physiol. 1999;276:R441\u20139.","journal-title":"Am J Physiol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01147-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:21:07Z","timestamp":1780993267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01147-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01147-x","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal use in this study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals as outlined by the U.S. National Institutes of Health and was approved by the Animal Care and Use Committee at Albert Einstein College of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}